The Oslo Chronic Fatigue Consortium (OCFC) brings together more than 100 clinicians and researchers from Norway, the wider ...

Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized controlled trial to show large and very large ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Placebo-controlled clinical trial with 900 COVID-19 patients shows success of a new patent-protected compound from the Cluster of Excellence PMI in Kiel (Germany). / An innovative nutritional ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests return normal ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight ...

The findings of the study published in journal PLOS One showed that obesity was significantly associated with a persistent ...

Patients suffering from long ... long COVID cohort. “We found a range of cardiopulmonary inflammatory patterns, backed by abnormal protein profiles,” Dr. Trivieri says. “These insights ...

Five years after the pandemic’s start, millions of Americans are still struggling with long-lasting symptoms of Covid-19. Cognitive difficulties are among the most troubling and common symptoms ...